633 related articles for article (PubMed ID: 26543364)
1. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
[TBL] [Abstract][Full Text] [Related]
2. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model.
Garg NK; Singh B; Tyagi RK; Sharma G; Katare OP
Colloids Surf B Biointerfaces; 2016 Nov; 147():17-24. PubMed ID: 27478959
[TBL] [Abstract][Full Text] [Related]
3. Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.
Hildner K; Finotto S; Becker C; Schlaak J; Schirmacher P; Galle PR; Märker-Hermann E; Neurath MF
Clin Exp Immunol; 1999 Oct; 118(1):137-46. PubMed ID: 10540171
[TBL] [Abstract][Full Text] [Related]
4. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
5. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
[TBL] [Abstract][Full Text] [Related]
7. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of the effectiveness of poly(ε-caprolactone) lipid-core nanocapsules loaded with methotrexate on glioblastoma multiforme treatment.
Pereira NRC; Loiola RA; Rodrigues SF; de Oliveira CP; Büttenbender SL; Guterres SS; Pohlmann AR; Farsky SH
Int J Nanomedicine; 2018; 13():4563-4573. PubMed ID: 30154652
[TBL] [Abstract][Full Text] [Related]
9. Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients.
Singh R; Jadhav K; Kamboj R; Malhotra H; Ray E; Jhilta A; Dhir V; Verma RK
Biomater Adv; 2024 Jun; 160():213853. PubMed ID: 38636119
[TBL] [Abstract][Full Text] [Related]
10. Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis.
Mello SB; Tavares ER; Bulgarelli A; Bonfá E; Maranhão RC
Int J Nanomedicine; 2013; 8():443-9. PubMed ID: 23439784
[TBL] [Abstract][Full Text] [Related]
11. [Effect of Combination Therapy of Tetramethylpyrazine with Methotrexate on Inflammatory Reac- tions and Hemorheology in Collagen-induced Arthritis Rats].
Bian YQ; Xu SH; Guo HT; Luo D; Xiao C; Lu C; Zhao HY; He XJ; Lu Ai-ping
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jun; 35(6):724-9. PubMed ID: 26242127
[TBL] [Abstract][Full Text] [Related]
12. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate chronotherapy is effective against rheumatoid arthritis.
To H; Yoshimatsu H; Tomonari M; Ida H; Tsurumoto T; Tsuji Y; Sonemoto E; Shimasaki N; Koyanagi S; Sasaki H; Ieiri I; Higuchi S; Kawakami A; Ueki Y; Eguchi K
Chronobiol Int; 2011 Apr; 28(3):267-74. PubMed ID: 21452922
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.
Neurath MF; Hildner K; Becker C; Schlaak JF; Barbulescu K; Germann T; Schmitt E; Schirmacher P; Haralambous S; Pasparakis M; Meyer Zum Büschenfelde KH; Kollias G; Märker-Hermann E
Clin Exp Immunol; 1999 Jan; 115(1):42-55. PubMed ID: 9933419
[TBL] [Abstract][Full Text] [Related]
15. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
[TBL] [Abstract][Full Text] [Related]
16. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate.
Miranda-Carús ME; Balsa A; Benito-Miguel M; Pérez de Ayala C; Martín-Mola E
J Immunol; 2004 Jul; 173(2):1463-76. PubMed ID: 15240743
[TBL] [Abstract][Full Text] [Related]
17. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
18. Development of Albumin Coupled, Cholesterol Stabilized, Lipid Nanoemulsion of Methotrexate, and TNF-α Inhibitor for Improved In Vivo Efficacy Against Rheumatoid Arthritis.
Li XY; Li H; Zhang Y; Gao S; Dong CP; Wu GF
AAPS PharmSciTech; 2017 Oct; 18(7):2774-2782. PubMed ID: 28361455
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate diethyl ester-loaded lipid-core nanocapsules in aqueous solution increased antineoplastic effects in resistant breast cancer cell line.
Yurgel VC; Oliveira CP; Begnini KR; Schultze E; Thurow HS; Leon PM; Dellagostin OA; Campos VF; Beck RC; Guterres SS; Collares T; Pohlmann AR; Seixas FK
Int J Nanomedicine; 2014; 9():1583-91. PubMed ID: 24741306
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
